Amgen Inc. (AMGN): A Bull Case Theory

We came across a bullish thesis on Amgen Inc. (AMGN) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc. (AMGN)’s share was trading at $281.22 as of May 2nd. AMGN’s trailing and forward P/E were 25.64 and 13.48 respectively according to Yahoo Finance.

A doctor in a laboratory conducting experiments to develop new biopharmaceutical drugs.

Amgen (AMGN) delivered a strong first-quarter performance in 2025, with total revenue rising 9%...